This powerful drug combo cuts prostate cancer deaths by 40%

Men whose prostate cancer returns after surgery or radiation therapy may soon benefit from a powerful new treatment that has been shown in clinical trials to reduce the risk of death by more than 40%. Researchers tested a therapy that combines enzalutamide, an existing cancer drug, with standard hormone therapy. This approach significantly lowered death…

Read More

Even “diet” soda may be quietly damaging your liver, scientists warn

A large-scale investigation has found that people who regularly consume both sugar-sweetened beverages (SSBs) and low- or no-sugar-sweetened beverages (LNSSBs) face a significantly greater likelihood of developing metabolic dysfunction-associated steatotic liver disease (MASLD).1 Presented at UEG Week 2025, the research followed 123,788 adults from the UK Biobank who had no signs of liver disease at…

Read More

Google AI Studio updates: More control, less friction

We’ve made it easier to find and switch between Google’s latest AI models. The new Playground is a single, unified surface where you can use Gemini, GenMedia (with new Veo 3.1 capabilities), text-to-speech (TTS) and Live models, all without losing your place or switching tabs. We’ve also refined the entire Chat UI for better consistency,…

Read More

Stanford scientists grow thousands of mini human brains using common food additive

For nearly ten years, the Stanford Brain Organogenesis Program has been redefining how scientists study the human brain. Instead of relying on intact brain tissue from humans or animals, researchers in the program grow three-dimensional brain-like structures in the lab using stem cells. These tiny models, called human neural organoids and assembloids, allow scientists to…

Read More